Skip to content
Trial Eligibility
Menu

Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain

NCT05265546

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The long-term objective of this project is to characterize how psilocybin affects visual perception and the brain's representation of the visual environment. It is known that psilocybin alters aspects of visual perception, but the underlying brain mechanisms contributing to these effects are poorly understood. The proposed work will address these questions in a large, diverse sample of healthy human subjects by using functional magnetic resonance imaging (fMRI) to measure the brain's responses to visual stimuli.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Perception Disorders

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
21 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, Berkeley
Last updated on ClinicalTrials.gov
July 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California, Berkeley · Berkeley, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.